These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 740683)

  • 1. Biological activity of endogenous and exogenous calcitonin in patients with osteitis fibrosa and chronic renal failure.
    Cundy T; Heynen G; Paton S; Ledingham JG; Russell RG; Oliver DO; Kanis JA
    Proc Eur Dial Transplant Assoc; 1978; 15():524-31. PubMed ID: 740683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
    Brossard JH; Garon J; Lepage R; Gascon-Barré M; D'Amour P
    Bone Miner; 1993 Oct; 23(1):15-26. PubMed ID: 8274876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal osteodystrophy in two children : a comparison of the effects of 1 alpha-hydroxycholecalciferol (author's transl)].
    Chantraine JM; Davin JC; Lambrechts L; Heynen G
    Ann Endocrinol (Paris); 1979; 40(2):161-2. PubMed ID: 475307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.
    Andress DL; Norris KC; Coburn JW; Slatopolsky EA; Sherrard DJ
    N Engl J Med; 1989 Aug; 321(5):274-9. PubMed ID: 2631697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormonal markers of early-stage osteitis fibrosa in patients on hemodialysis].
    Persichetti S; Sagliaschi G; Clemenzia G; Angelitti A; Gallo G; Maggi S; Ponzio R; Punzo G; Tozzo C
    Minerva Med; 1992 Nov; 83(11):721-4. PubMed ID: 1461543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diurnal changes in the levels of immunoreactive parathyroid hormone and calcitonin in patients with chronic renal insufficiency].
    Ivić MA; Bogićević M; Djordjević V; Mitić M; Stefanović V
    Srp Arh Celok Lek; 1992; 120(5-6):141-5. PubMed ID: 1465667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postparathyroidectomy hypocalcemia as an accurate indicator of preparathyroidectomy bone histology in the uremic patient.
    Felsenfeld AJ; Gutman RA; Llach F; Harrelson JM; Wells SA
    Miner Electrolyte Metab; 1984; 10(3):166-72. PubMed ID: 6727802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathology of renal osteodystrophy with particular reference to the effects of 1alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysis.
    Ellis HA; Pierides AM; Feest TG; Ward MK; Kerr DN
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():31s-38s. PubMed ID: 606422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitation by hyperphosphataemia of the "prophylactic" use of vitamin D metabolites in the treatment of osteitis fibrosa in patients on chronic haemodialysis.
    de Fremont JF; Sebert JL; Gueris J; Marie P; Coevoet B; Makdassi R; Lambrey G; Meunier P; Fournier A
    Proc Eur Dial Transplant Assoc; 1979; 16():675-6. PubMed ID: 232918
    [No Abstract]   [Full Text] [Related]  

  • 11. Deterioration of renal bone disease in patients treated with salmon calcitonin.
    Cundy T; Kanis JA; Heynen G; Paton S; Earnshaw M; Woods CG
    Clin Endocrinol (Oxf); 1982 Jan; 16(1):29-37. PubMed ID: 7042129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phosphorus and calcium metabolism and its hormonal regulation in chronic kidney failure].
    Nikiforova NV; Strunin SE; Ermolenko VM; Mozzhechkov VT; Khomiakova VN
    Ter Arkh; 1985; 57(1):103-7. PubMed ID: 3983831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of calcium infusion on calcitonin and parathyroid hormone concentrations in normal and hemodialyzed subjects.
    Isaac R; Nivez MP; Piamba G; Fillastre JP; Ardaillou R
    Clin Nephrol; 1975 Jan; 3(1):14-7. PubMed ID: 1126058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parathyrin and calcitonin in patients with chronic renal insufficiency].
    Dzhavad-Zade MD; Agaev MM; Karaev ME
    Med Radiol (Mosk); 1985 Dec; 30(12):47-9. PubMed ID: 4079692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPD.
    Martínez ME; Miguel JL; Gómez P; Selgas R; Salinas M; Gentil M; Mateos F; Montero JL; Sánchez Sicilia L
    Clin Nephrol; 1983 May; 19(5):250-3. PubMed ID: 6851265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
    Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
    Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
    [No Abstract]   [Full Text] [Related]  

  • 17. Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.
    Pierides AM; Ellis HA; Simpson W; Dewar JH; Ward MK; Kerr DN
    Lancet; 1976 May; 1(7969):1092-5. PubMed ID: 57505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma parathormone, calcium and phosphorus in patients with renal osteodystrophy undergoing chronic hemodialysis.
    Genuth SM; Sherwood LM; Vertes V; Leonards JR
    J Clin Endocrinol Metab; 1970 Jan; 30(1):138-40. PubMed ID: 5409532
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma calcitonin in renal osteodystrophy.
    Chittal SM; Oreopoulos DG; DeVeber GA; Thomas P; Rabinovich S; Lloyd GJ; Kumar MA; Rapoport A
    Can Med Assoc J; 1971 Jun; 104(12):1098-100. PubMed ID: 4931771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic hyperparathyroidism associated with C-cell hyperplasia of the thyroid gland].
    Kuhlencordt F; Kracht J
    Dtsch Med Wochenschr; 1968 Dec; 93(50):2411-5 passim. PubMed ID: 5698973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.